Chief Executive Robert Ford said the company's "No. 1 priority is getting infants and families the high-quality formulas they need." Abbott Labs Enters Into Consent Decree With FDA at 4:40 p.m. ET incorrectly said the priority was No. 2.

 

(END) Dow Jones Newswires

May 16, 2022 17:45 ET (21:45 GMT)

Copyright (c) 2022 Dow Jones & Company, Inc.
Abbott Laboratories (NYSE:ABT)
Gráfico Histórico do Ativo
De Jun 2022 até Jul 2022 Click aqui para mais gráficos Abbott Laboratories.
Abbott Laboratories (NYSE:ABT)
Gráfico Histórico do Ativo
De Jul 2021 até Jul 2022 Click aqui para mais gráficos Abbott Laboratories.